Computed tomography screening for lung carcinoma in Japan

Citation
M. Kaneko et al., Computed tomography screening for lung carcinoma in Japan, CANCER, 89(11), 2000, pp. 2485-2488
Citations number
10
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER
ISSN journal
0008543X → ACNP
Volume
89
Issue
11
Year of publication
2000
Supplement
S
Pages
2485 - 2488
Database
ISI
SICI code
0008-543X(200012)89:11<2485:CTSFLC>2.0.ZU;2-Y
Abstract
BACKGROUND. In Japan, lung carcinoma is the leading cause of cancer-related deaths. Adenocarcinoma accounts for roughly half of all lung carcinomas. E arlier detection of lung carcinoma is expected to reduce mortality rates. C omputed tomography (CT) provides higher contrast resolution and greater vis ualization of chest compartments that are difficult to view with chest radi ography, such as the mediastinum. CT further permits the detection of minut e peripheral nodules. At present, several institutions and research groups are evaluating the utility of low dose spiral CT for lung carcinoma screeni ng. METHODS. From September 1993 to December 1998, 1669 individuals underwent a biannual screening program for lung carcinoma. The program included poster oanterior radiograph, sputum cytology, and low dose spiral CT at a for-prof it organization: The Anti-Lung Cancer Association (ALCA). A total of 9993 e xaminations were carried out. The low dose spiral CT parameters used were 1 20 kvP, 50 mA, 10-mm collimation, and 2:1 pitch. RESULTS. Peripheral lung carcinoma was detected in 31 of 9993 examinations (0.3%). Of the 31 cases, 24 tumors (77%) were detected by low dose spiral C T but were not visible on standard chest radiography. Twenty-two of the 24 tumors were Stage IA (T1N0M0, according to staging system revised in 1997). CONCLUSIONS. Low dose spiral CT shows promise for lung carcinoma screening. The effectiveness of the technique for the detection of minute lung lesion s remains to be established. Routine use of the technique will require reso lution of several issues. These issues include the establishment of CT diag nostic criteria, the development of a diagnostic support system, the establ ishment of methods for definite diagnosis, and assessments of efficacy. Can cer 2000;89:2485-8. (C) 2000 American Cancer Society.